CME Group Acquires NEX Group, Expects Cost Synergies of Up to $200 Mn Annually by 2021 - The Industry Spread

Karthik Subramanian

Karthik Subramanian has been a professional trader and fund manager over the last 18 years. He is basically a software developer who made the transition to financial domain around 18 years back as the attractiveness of the financial markets proved too much for him. He lives in Chennai in India along with his wife and son. He began his career as a software developer in 1999 and then gradually moved into the financial industry as he began trading stocks in his pastime. He then moved into the financial markets full time and then shifted his focus to the FX markets due to the liquid nature of these markets. Since then, he has been trading FX diligently and his favourite pair are the EURUSD and EURJPY. Over the last couple of years, he has found blockchain to be of high interest and considering his background in software and finance, he has since assembled a team of highly talented developers who have since worked on a variety of projects like crypto exchanges and blockchain architecturing. Now, he balances his time between trading and commenting on both the FX and crypto markets. He has worked with many publications including FX Street and Finance Magnates, which has helped him gain experience and also recognition across the industry. He loves to write and this passion has helped him to reach out across the FX and crypto industry. Right now, he works on his pet projects in the FX and crypto industry and spends his time writing and managing his blockchain team and helping it to reach higher.

NEX Group

CME Group Acquires NEX Group, Expects Cost Synergies of Up to $200 Mn Annually by 2021

July 5, 2018

CME GroupThe CME Group ( NASDAQ: CME) and NEX Group Plc. has reached a definitive agreement on the acquisition of the latter by former and is valued at £10 per share. CME Group will pay out 500 pence in cash and 0.0444 CME Group shares based on the trading price on 28th March 2018, ie $158.84 and the exchange rate of $1.4101:£1, on March 28, 2018. The transaction has been approved by the board of both the entities and is expected to close the deal in the second half of 2018, pending approvals by regulators and NEX shareholders,

Through this deal, CME Group will able to improve its trading technology and streamline access by the reducing touch points that clients need to trade across products. Also, NEX’s OTC post-trade products and services complement CME Group’s derivatives clearing services. It will also help in strengthening the NEX compression, reconciliation and processing businesses.

CME Group Chairman and Chief Executive Officer Terry Duffy said on the development: 

“At a time when market participants are seeking ways to lower trading costs and manage risk more effectively, this acquisition will allow us to create significant value and efficiencies for our clients globally. As one organization, we will be able to employ the complementary strengths of each company to serve a wider client base while diversifying our combined businesses across futures, cash and OTC products and post-trade services.”

He added: “Michael Spencer and his senior leadership team have built a world-class organization that is at the centre of capital markets. We are committed to maintaining the longstanding relationships NEX has with its clients, and exchange and clearinghouse partners. Building on NEX’s deep roots in Europe and Asia and CME’s strong technology platform, we will transform our international profile and broaden our distribution network in spot and futures FX products as well as cash, repo and futures products in U.S. Treasuries.”

Post completion of the acquisition process, NEX CEO Michael Spencer will be appointed to the Board of Directors of CME Group and will also serve Special Advisor of the combined entity. He will also be the ambassador of the combined entity working with key clients, regulatory authorities in EMEA and Asia. Spencer commented:

“The combination of NEX and CME will be an industry-changing transaction. Bringing together cash and futures products and OTC services will be unique, offering clients improved access to trading, greater financial efficiencies and highly valuable data sets. The technology and innovation opportunities will be diverse and extraordinary. Clients will be better served. CME’s decision to choose London as its European headquarters is also a signal of tremendous support for Britain’s financial services sector.”

According to the terms of the transaction, each NEX share will be entitled to 500 pence in cash and 0.0444 shares of CME Group Class A common stock. The deal is likely to be immediately accretive to adjusted cash earnings per share and run-rate cost synergies are expected to touch $200 million annually by the end of 2021. JP Morgan is acting as a lead financial advisor while Barclays is acting as financial advisor to the CME Group.

Login To MyTis Comment Or Register to MyTIS

Leave a Reply

avatar
  Subscribe  
Notify of

Newsletter

Register now to receive the latest news and information for global trading industry.

Latest Articles

Tools for Brokers

Tools for Brokers Enhances Quote Aggregation and Trading Execution

Tools for Brokers has enhanced the Trade Processor system with the ability to aggregate quote feeds and trading execution in the liquidity pool based on which has the best current …